epigallocatechin gallate has been researched along with phenylephrine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aggio, A; D'Alessandro, A; Ferri, C; Grassi, D; Masedu, F; Onori, E; Valenti, M | 1 |
| Kawamura, R; Kobayashi, T; Matsumoto, T; Taguchi, K; Watanabe, S | 1 |
2 other study(ies) available for epigallocatechin gallate and phenylephrine
| Article | Year |
|---|---|
Endothelium/nitric oxide mechanism mediates vasorelaxation and counteracts vasoconstriction induced by low concentration of flavanols.
Topics: Animals; Aorta, Thoracic; Catechin; Endothelium, Vascular; Male; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Phenylephrine; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Vasoconstriction; Vasodilation; Vasodilator Agents | 2013 |
Epigallocatechin gallate attenuates ET-1-induced contraction in carotid artery from type 2 diabetic OLETF rat at chronic stage of disease.
Topics: Acetylcholine; Animals; Carotid Arteries; Catechin; Chronic Disease; Diabetes Mellitus, Experimental; Endothelin-1; In Vitro Techniques; Male; NADPH Oxidases; Nitric Oxide Synthase Type III; Nitroprusside; Phenylephrine; Rats, Inbred OLETF; Receptors, Endothelin; Superoxide Dismutase; Vasoconstriction; Vasodilation | 2014 |